Who invested in Menlo Therapeutics?
Menlo Therapeutics's investors include F-Prime Capital, Bay City Capital, Presidio, Remeditex and Rock Ventures, and 3 more on record.
United States · Series C startup
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2017, from 1 source
Reported by FinSMEsSEC filing: $51M sold, first sale Jul 2017
From the SEC filings it signed: 1 on the team.
On the board, as filediAaron L. RoystonAlbert L. ChaDavid L. CollierJohn L. CreecyKetan L. PatelScott L. WhitcupTed L. Ebel
Menlo Therapeutics's investors include F-Prime Capital, Bay City Capital, Presidio, Remeditex and Rock Ventures, and 3 more on record.
Menlo Therapeutics has raised $50M across 1 round since 2017.
Menlo Therapeutics's most recent round was a Series C of $50M in Jul 2017.
Its most recent round, $50M in Jul 2017, is also its largest on record.
Menlo Therapeutics's first round on record, in Jul 2017, was backed by F-Prime Capital, Bay City Capital and Presidio and 5 others.
Menlo Therapeutics's latest named round is a Series C, in Jul 2017.
Menlo Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.